Mallinckrodt Enterprises | Mallinckrodt | North Carolina | state | 2012 | $441,576 | | tax credit/rebate |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $751,067 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2012 | $2,467,398 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2012 | $6,651,352 | | tax credit/rebate |
Amgen USA, Inc. | Amgen | North Carolina | state | 2012 | $3,274 | | tax credit/rebate |
Alpharma Specialty Pharma, Inc. | Pfizer | North Carolina | state | 2012 | $3,885 | | tax credit/rebate |
Mallinckrodt Enterprises Holdings, Inc. | Mallinckrodt | North Carolina | state | 2012 | $3,891 | | tax credit/rebate |
Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals | North Carolina | state | 2012 | $5,319 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2012 | $5,602 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2012 | $12,443 | | tax credit/rebate |
EMD Serono, Inc. | Merck KGaA (EMD) | North Carolina | state | 2012 | $13,576 | | tax credit/rebate |
BioCryst Pharmaceuticals, Inc. | Biocryst Pharmaceuticals | North Carolina | state | 2012 | $15,915 | | tax credit/rebate |
Boehringer-Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | North Carolina | state | 2012 | $16,858 | | tax credit/rebate |
Amgen, Inc. | Amgen | North Carolina | state | 2012 | $20,827 | | tax credit/rebate |
Embrex, Inc. | Pfizer | North Carolina | state | 2012 | $32,718 | | tax credit/rebate |
Icagen, Inc. | Pfizer | North Carolina | state | 2012 | $54,345 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2012 | $65,595 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2012 | $98,209 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $112,006 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2012 | $169,007 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2012 | $218,644 | | tax credit/rebate |
UCB Biosciences, Inc. | UCB | North Carolina | state | 2012 | $296,213 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2012 | $607,213 | | tax credit/rebate |
GlaxoSmithKline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2012 | $4,025,543 | | tax credit/rebate |
Dr. Reddy's Laboratories Tennessee, LLC | Dr. Reddy's Laboratories | Tennessee | state | 2013 | $312,500 | | training reimbursement |
Aldrich Chemical | Merck KGaA (EMD) | Wisconsin | state | 2003 | $2,426,984 | | tax increment financing |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2010 | $1,250,000 | | tax credit/rebate |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2012 | $2,000,000 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2013 | $350,000 | | tax credit/rebate |
Eli Lilly dba Elanco Animal Health | Eli Lilly | Indiana | state | 2013 | $500,000 | | grant |
Disetronic Medical Systems, Incorporated | Roche | Indiana | state | 2005 | $20,000 | | training reimbursement |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2007 | $101,500 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2008 | $200,000 | | training reimbursement |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2009 | $310,000 | | training reimbursement |
Bristol-Myers Squibb Co. dba Mt. Vernon Technical Operations | Bristol-Myers Squibb | Indiana | state | 2009 | $137,500 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2010 | $50,000 | | training reimbursement |
Kremers Urban Pharmaceuticals Inc. | Lannett Co. | Indiana | state | 2011 | $200,000 | | training reimbursement |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2012 | $300,000 | | training reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2012 | $50,000 | | training reimbursement |
Mylan Laboratories, Inc. | Viatris | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Mylan Laboratories, Inc. | Viatris | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Mylan Laboratories, Inc. | Viatris | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Alpharma, Inc. | Pfizer | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Mylan Laboratories, Inc. | Viatris | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Mylan Laboratories, Inc. | Viatris | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Mylan Laboratories, Inc. | Viatris | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Mylan Laboratories, Inc. | Viatris | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Mylan Laboratories, Inc. | Viatris | West Virginia | state | 2007 | undisclosed | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2012 | $40,000 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2012 | $60,750 | | tax credit/rebate |
Aegerion Pharmaceuticals, Inc. | Amryt Pharma | Massachusetts | state | 2012 | $96,303 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2012 | $98,270 | | tax credit/rebate |
Blueprint Medicines Corporation | Blueprint Medicines | Massachusetts | state | 2012 | $100,000 | | tax credit/rebate |
LightLab Imaging, Inc | Abbott Laboratories | Massachusetts | state | 2012 | $121,636 | | tax credit/rebate |
PAREXEL International Corporation | Parexel International | Massachusetts | state | 2012 | $150,000 | | tax credit/rebate |
LightLab Imaging, Inc | Abbott Laboratories | Massachusetts | state | 2012 | $515,000 | | tax credit/rebate |
Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals | Massachusetts | state | 2012 | $880,128 | | tax credit/rebate |
DePuy Othopaedics, Inc. | Johnson & Johnson | Massachusetts | state | 2012 | $1,224,300 | | tax credit/rebate |
Momenta Pharmaceuticals, Inc | Johnson & Johnson | Massachusetts | state | 2012 | $1,224,300 | | tax credit/rebate |
Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals | Massachusetts | state | 2012 | $1,568,471 | | tax credit/rebate |
Ironwood Pharmaceuticals, Inc | Ironwood Pharmaceuticals | Massachusetts | state | 2012 | $1,836,449 | | tax credit/rebate |